Health Care Providers

At Atossa Genetics our goal is to work with the healthcare community to make available tools to assist in providing the best care for patients. Through research, education, and new product introduction we are dedicated to reducing the incidence of breast cancer and to improving the quality of life for those with cancer.

Here you will find the NAF library, Topics of Interest, and our Certifications to keep you up-to-date on the use of Nipple Aspirate Fluid (NAF) collection as an adjunct to mammography in identifying high risk women.

Topics of Interest

Breast Anatomy and Nipple Aspirate Fluid (NAF) Collection

The female breast has two main components; glandular tissue (lobes and ducts) and connective tissue. The breast is divided into 15 to 20 lobes that radiate outwards from the nipple and contain clusters of milk-producing glands. The lobes are… read more

MASCT System Clinical Testing

A clinical trial of the MASCT System was performed at the State University of New York, Stony Brook, NY to test the efficiency of NAF collection in normal volunteer women. Thirty-one healthy, non-pregnant, pre-menopausal female subjects… read more

The Role of NAF Cytology in the Identification of Atypical Ductal Hyperplasia

Atypical ductal hyperplasia (ADH) is a condition in which the cells lining the breast duct grow excessively and abnormally. Without other risk factors, it produces a five-fold increased risk of breast cancer. With a family history… read more

Preventing Breast Cancer with Medical Treatment

Drug therapy clinical trials for preventing breast cancer in high risk women are called chemoprevention trials. In a five year chemoprevention study of 19,700 women with ADH or other factors that made them at a high risk for invasive… read more

Diets Can improve NAF Findings

Changes in diet and/or the use of dietary supplements can have an impact on breast cancer occurrence and the effect can be measured by changes in NAF cytology or the presence of biomarkers in NAF. A study of the affect of dietary… read more

The Role of NAF Cytology and Molecular Diagnostic Biomarkers in Screening for Breast Cancer

The sensitivity of a test for detecting an abnormality is an important measure in screening populations for the presence of occult disease. With mammography as the well accepted Gold Standard for breast cancer screening, a comparison… read more

NAF Testing in Women with Prior Breast Cancer

Women who have had breast cancer are at a higher risk for recurrence of cancer or for a new malignancy. In 2008, there were 2.5 MM breast cancer survivors in the US. Atossa believes these women would be candidates for regular… read more

NAF Testing and Risk Assessment

The Breast Cancer Risk Assessment Tool (based on the Gail model) has been established by the National Cancer Institute (NCI) and the National Surgical Adjuvant Breast and Bowel Project (NSABP) to identify women with an increased… read more